C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2009
11/12/2009	US20090280502 Anti-2-o-desulfated acharan sulfate antibody and its application
11/12/2009	US20090280499 Method and kit for detecting, or determining 3,4- methylenedioxymethamphetamine
11/12/2009	US20090280482 Novel nucleic acid sequences encoding adenylate kinases, alcohol dehydrogenases, ubiquitin proteases, lipases, adenylate cyclases, and GTPase activators
11/12/2009	US20090280455 Interactive dental restorative network
11/12/2009	US20090280168 Chlamydia polypeptides used to prevent, treat, and diagnose Chlamydia infection; 98 KDa OMP antigen designated CPN100686 RY 54
11/12/2009	US20090280141 Streptococcal Genes
11/12/2009	US20090280138 Peptide
11/12/2009	US20090280132 Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease
11/12/2009	US20090280131 IL-17 Antagonistic Antibodies
11/12/2009	US20090280128 Anti-ilt7 antibody
11/12/2009	US20090280127 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-i
11/12/2009	US20090280126 biological fragments comprising polypeptides, in a combination with phosphatides, used for for immunization or treatment of ischemic cardiovascular disorders, in humans
11/12/2009	US20090280125 Prion epitopes and methods of use thereof
11/12/2009	US20090280124 Methods for the Diagnosis and Treatment of Preeclampsia
11/12/2009	US20090280120 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
11/12/2009	US20090280118 antibody that binds the same epitope of alpha v beta 5 as bound by ALULA ; Pulmonary edema
11/12/2009	US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
11/12/2009	US20090280116 Humanized antibodies against tl1a
11/12/2009	US20090280110 Cell Model for Alzheimer's Disease Pathology
11/12/2009	US20090280106 Pituitary adenylate cyclase acivating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
11/12/2009	US20090280105 Novel Fungal Enzymes
11/12/2009	US20090280082 Methods for treating autoimmune disorders
11/12/2009	US20090280065 Uses and Compositions for Treatment of Psoriasis
11/12/2009	US20090280056 Antibodies and immunoconjugates and uses therefor
11/12/2009	CA2723842A1 Amino acid sequences directed against integrins and uses thereof
11/12/2009	CA2723722A1 Igf-ii/gf-iie binding proteins
11/12/2009	CA2723698A1 Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
11/12/2009	CA2723323A1 Use of a radioactively labelled molecule specifically binding to ed-b fibronectin in a method of treatment of hodgkin lymphoma
11/12/2009	CA2723219A1 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
11/12/2009	CA2722622A1 Humanized antibodies against human interferon-alpha
11/12/2009	CA2721713A1 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
11/12/2009	CA2720904A1 Novel antibodies used to treat cancer
11/11/2009	EP2116616A2 Genes differentially expressed in activated T cells and uses thereof
11/11/2009	EP2116615A1 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
11/11/2009	EP2116596A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
11/11/2009	EP2116556A1 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
11/11/2009	EP2116555A1 Use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of treatment of Hodgkin lymphoma
11/11/2009	EP2116262A2 Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
11/11/2009	EP2116261A1 Sub-region of a plasmodium protein with improved vaccine potential and medical uses thereof
11/11/2009	EP2116259A1 TACI-immunoglobulin fusion proteins
11/11/2009	EP2115476A2 Methods and biomarkers for diagnosing and monitoring psychotic disorders
11/11/2009	EP2115470A1 An activation epitope of fcy rii (cd32), binding molecules that specifically bind the epitope and means and methods for the detection of the epitope, and uses of said epitope or said binding molecules
11/11/2009	EP2115464A2 Methods and compositions for determining the efficacy of breast cancer therapeutics
11/11/2009	EP2115151A2 Methods and vectors for generating asialylated immunoglobulins
11/11/2009	EP2115139A1 Method for producing novel ige based reagents
11/11/2009	EP2115129A2 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr)
11/11/2009	EP2115007A2 Binding members for ige molecules
11/11/2009	EP2115006A2 Humanized antibodies against cxcr3
11/11/2009	EP2115005A2 Novel antibodies againgt igf-ir
11/11/2009	EP2115004A2 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
11/11/2009	EP2115003A2 Human antibodies to human delta like ligand 4
11/11/2009	EP2115002A2 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells
11/11/2009	EP2115001A1 Coupling of antibody polypeptides at the c-terminus
11/11/2009	EP2114996A1 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens
11/11/2009	EP2114985A2 Multivariable antigens complexed with targeting humanized monoclonal antibody
11/11/2009	EP2114451A2 Anti-il-13 antibody formulations and uses thereof
11/11/2009	EP2114436A1 Trkb agonists for treating autoimmune disorders
11/11/2009	EP2114422A1 Osteopontin for the prediction and treatment of cardiovascular diseases
11/11/2009	EP1664097B1 Piroplasmid vaccine
11/11/2009	EP1603541B1 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/11/2009	EP1519960B1 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof
11/11/2009	EP1498421B1 Gamma-secretase inhibitors
11/11/2009	EP1317278B1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
11/11/2009	EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same
11/11/2009	EP1181314B1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
11/11/2009	EP0876509B2 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
11/11/2009	CN101578298A Ligands that bind IL-4 and/or IL-13
11/11/2009	CN101578297A Antibody compositions and methods for treatment of neoplastic disease
11/11/2009	CN101578296A Human monoclonal antibodies to BTLA and methods of use
11/11/2009	CN101578295A Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma
11/11/2009	CN101578113A Anti-KIR antibodies, formulations, and uses thereof
11/11/2009	CN101575593A Vaccine for hand-foot-mouth disease and preparation method and application thereof
11/11/2009	CN101575377A Human cytokine as ligand of zalpha receptor and use thereof
11/11/2009	CN101575376A Anti-human rBPI23 monoclonal antibody and applications thereof
11/11/2009	CN101575375A Human apolipoprotein AV monoclonal antibody and application thereof
11/11/2009	CN101575374A Chicken Marek's virus antibody and preparation method thereof
11/11/2009	CN101574520A Methods of administering anti-TNF alpha antibodies
11/11/2009	CN100558895C The anti-platelet membrane glycoprotein VI monoclonal antibody
11/11/2009	CN100558746C Kit for assaying human low-molecular weight CD14 and antibody
11/11/2009	CN100558399C Vaccine comprising a tick cement protein
11/10/2009	US7615679 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs
11/10/2009	US7615616 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections
11/10/2009	US7615611 Human cytokine receptor
11/10/2009	US7615529 Methods and compositions for modulating hyperstabilized c-met
11/10/2009	US7615383 Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodies
11/10/2009	US7615379 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
11/10/2009	US7615229 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2009	US7615226 Antigen is mixed with at antigen is mixed with at least one adjuvant and the mixture subsequently is heat-treated
11/10/2009	US7615225 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen
11/10/2009	US7615224 Multiplex-bead complex for determination of lysosomal storage disorders
11/10/2009	US7615223 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases
11/10/2009	US7615220 High affinity human antibodies to human IL-18 receptor
11/10/2009	US7615219 Treatment of decreased blood platelet numbers by neutralizing anti-PACAP antibody or antigen-binding fragment; haemostasis
11/10/2009	US7615217 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/10/2009	US7615215 Endothelial growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of vision, inflammatory, diabetic and cell proliferative disorders
11/10/2009	US7615214 For abnormal angiogenesis, such as proliferation or metastasis of solid tumors, arthritis in rheumatoid arthritis, diabetic retinopathy, retinopathy of prematurity, psoriasis
11/10/2009	US7615213 Respiratory disorders (asthma); atopic disorders (allergic rhinitis); inflammatory and/or autoimmune conditions of the skin ( atopic dermatitis), and gastrointestinal organs ( inflammatory bowel diseases (IBD)), as well as fibrotic and cancerous disorders
11/10/2009	US7615212 Administering to the joint having systemic onset juvenile idiopathic arthritis an active agent that will reduce the bioavailability of interleukin-1 beta (IL-1 beta) by modifying the transcription, translation or gene expression or by blocking the IL-1 beta recepter;antiinflammatory agent; antipyretics
11/10/2009	US7615211 CD70 inhibition for the treatment and prevention of inflammatory bowel disease
11/10/2009	CA2479476C Compositions and methods for the treatment of tumor

1 ... 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 ... 1494